-
Medical journals
- Career
Transfusion and Haematology Today - Issue 4/2004
137Is TEL/AML1 fusion gene appropriate marker for minimal residual disease monitoringin children with acute lymphoblastic leukaemia?J. Madžo, K. Mužíková, E. Froňková, L. Šrámková, L. Zemanová, J. Zuna, J. Starý, J. Trka
143Chronic lymphocytic leukemia: mutationalstatus of the immunoglobulin heavy chain gene is a significant prognostic markerV. Kuhrová, H. Francová, D. Klimešová, J. Mayer
149Immune-deficient mouse asa model for the study of leukaemiasM. Doubek, K. Řeháková, P. Scheer, J. Doubek, J. Mayer
154Anagrelide in the treatment of essential thrombocythemiaR. Pytlík, E. Cmunt, Z. Kleibl, T. Kozák
161
Transfusion and Haematology Today
2004 Issue 4
Most read in this issue- Is TEL/AML1 fusion gene appropriate marker for minimal residual disease monitoringin children with acute lymphoblastic leukaemia?
- Anagrelide in the treatment of essential thrombocythemia
- Chronic lymphocytic leukemia: mutationalstatus of the immunoglobulin heavy chain gene is a significant prognostic marker
- Immune-deficient mouse asa model for the study of leukaemias
Login#ADS_BOTTOM_SCRIPTS#Forgotten passwordEnter the email address that you registered with. We will send you instructions on how to set a new password.
- Career